What is the current market size and future outlook for the urinary incontinence & pelvic organ prolapse devices and equipment market?
The urinary incontinence & pelvic organ prolapse devices and equipment market size has grown strongly in recent years. It will grow from $4.01 billion in 2024 to $4.32 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to aging population, women’s health awareness, healthcare access, personalized treatment.
The urinary incontinence & pelvic organ prolapse devices and equipment market size is expected to see strong growth in the next few years. It will grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to minimally invasive techniques, emerging markets growth, value-based healthcare, regulatory support. Major trends in the forecast period include non-surgical treatment options, bioresorbable implants, digital health integration, enhanced patient education.
Get Your Free Sample of The Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2430&type=smp
How has the urinary incontinence & pelvic organ prolapse devices and equipment market evolved, and what factors have shaped its growth?
The increased prevalence rate for Pelvic organ prolapses (POP) as well as for urinary incontinence (UI) disorders has been driving the growth of urinary incontinence and pelvic organ prolapse (POP) devices and equipment market. The increasing prevalence rate has led manufacturers to develop more accurate and efficient devices for the treatment of these disorders. The POP affects women of all ages, however, old age women are more prone to POP disorders. According to US FDA reports, the number of women who have POP is expected to increase by 46%, to 4.9 million, by 2050. According to a report published by the American Urological Association (AUA/SUFU), the prevalence of stress urinary incontinence (SUI) in women was reported to be as high as 49%. The prevalence rate of stress urinary incontinence is high in the poor nutritional status group, as it results in weakness of pelvic supports. This high prevalence rate is driving the demand for medical equipment for urinary incontinence & pelvic organ prolapse devices and equipment market.
What are the major segments of the urinary incontinence & pelvic organ prolapse devices and equipment market?
The urinary incontinence & pelvic organ prolapse devices and equipment market covered in this report is segmented –
1) By Type: Urinary Incontinence Devices, Pelvic Organ Prolapse Devices
2) By Urinary Incontinence Devices: Artificial Urinary Sphincters, Electrical Stimulation Devices, Urethral Slings, Catheters
3) By Pelvic Organ Prolapse Devices: Vaginal Mesh, Vaginal Pessary
4) By Incontinence Type: Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Use
Subsegments:
1) By Urinary Incontinence Devices: Catheters (Intermittent, Indwelling, External), Absorbent Products (Pads, Adult Diapers), External Urinary Collection Devices, Electrical Stimulation Devices, Urethral Inserts, Artificial Urinary Sphincter
2) By Pelvic Organ Prolapse Devices: Vaginal Pessaries, Pelvic Floor Stimulation Devices, Surgical Implants, Prolapse Support Devices
Order your report now for swift delivery
Which companies dominate the urinary incontinence & pelvic organ prolapse devices and equipment market?
Major companies operating in the urinary incontinence & pelvic organ prolapse devices and equipment market include Boston Scientific Corporation, Coloplast A/S, Ethicon US, Becton Dickinson and Company, Johnson & Johnson, Teleflex Incorporated, Medtronic plc, COVIDien, Cook Medical, Neomedic International, CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical Inc., Thomas Medical, Kangge Medical, Dr. Arabin GmbH & Co. KG, American Medical Systems Inc., Caldera Medical Inc., Intuitive Surgical, InControl Medical LLC, Atlantic Therapeutics Ltd., Axonics Modulation Technologies, Convatec Group plc, Laborie, NUVO Group, Pelvalon, pfm medical, Promedon, Prosurg Inc., UROMED Kurt Drews KG, Verathon Inc., Vitality Medical, Women’s Choice Pharmaceuticals, Zimmer Biomet Holdings Inc.
How will evolving trends contribute to the growth of the urinary incontinence & pelvic organ prolapse devices and equipment market?
Major companies operating in urinary incontinence and pelvic organ prolapse devices and equipment are introducing innovative systems such as SOLTIVE Super Pulsed Laser System to increase their revenue in the market. SOLTIVE Premium Super Pulsed Laser System (SOLTIVE Laser System) offers the potential for shorter procedure times, better patient outcomes and lower procedure costs and is used for the treatment of urinary incontinence and other urological conditions such as removal of kidney stones. For instance, in January 2022, Olympus, a Japan-based company engaged in digital precision technology introduced the SOLTIVESuperPulsed Laser System that shortens kidney stone procedure time, and proves more cost-effective than Holmium. SOLTIVE Laser System reduces procedure time an average 20% and offers the potential for greater patient outcomes.
What are the major regional insights for the urinary incontinence & pelvic organ prolapse devices and equipment market, and which region holds the top position?
North America was the largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market in 2023. Western Europe was the second-largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market report. The regions covered in the urinary incontinence & pelvic organ prolapse devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Report 2025 Offer?
The urinary incontinence & pelvic organ prolapse devices and equipment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Urinary incontinence & pelvic organ prolapse devices and equipment are used in the treatment of pelvic organ prolapse and urinary incontinence. Urinary incontinence (UI), also known as involuntary urination, is defined as uncontrolled leakage of urine caused by an overactive bladder. Pelvic organ prolapse (POP) is caused by defects in the supporting structures of the vagina.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2430
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
